<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04140747</url>
  </required_header>
  <id_info>
    <org_study_id>28-524 ex 15/16</org_study_id>
    <nct_id>NCT04140747</nct_id>
  </id_info>
  <brief_title>Transfer of Strictly Anaerobe Microbes From Mother to Child</brief_title>
  <acronym>TRAMIC</acronym>
  <official_title>Transfer of Strictly Anaerobe Microbes From Mother to Child - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Graz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Graz</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate the changes in the microbiota at different body sites in late&#xD;
      pregnancy, in comparison with non-pregnant women, with particular emphasis on archaea, and to&#xD;
      identify possible maternal-to-child transfer routes for acquisition of strictly anaerobic&#xD;
      microorganisms by analyzing the gut microbiota of new born infants (delivered vaginally or by&#xD;
      C-section).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that changes occur in the microbial community during pregnancy&#xD;
      in different body sites (vagina, oral etc.) and that the main source of these microorganisms&#xD;
      is the mother for vaginally born infants, while C-section born infants acquire most of the&#xD;
      anaerobic microbial communities from other sources rather than mother's vaginal and gut&#xD;
      microbiota, such as the environment.&#xD;
&#xD;
      Specific Research Objectives will be:&#xD;
&#xD;
        1. To investigate diversity of archaea in the vagina of healthy women in the context with&#xD;
           community state types (CSTs), and compare vaginal microbiome in pregnant with&#xD;
           non-pregnant healthy women.&#xD;
&#xD;
        2. To identify the presence of archaea in different body sites (oral, gut) or body fluids&#xD;
           (amniotic fluid, urine, human milk) within the perinatal microbial communities.&#xD;
&#xD;
        3. To investigate the presence of archaea in the infant's first-days-of-life intestinal&#xD;
           community, and to identify the sources of these microorganisms by using source tracking&#xD;
           approach.&#xD;
&#xD;
        4. To investigate Human Milk Oligosaccharides (HMOs) in maternal (serum, saliva, urine,&#xD;
           breast milk) or intrauterine sources (amniotic fluid) as potential modifiers of the&#xD;
           microbial communities in these sites.&#xD;
&#xD;
        5. To analyze associations of maternal/ intrauterine HMOs with infant HMOs and microbiota&#xD;
           (meconium and infant stool) in order to investigate vertical transmission of microbiota&#xD;
           to the infant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 7, 2016</start_date>
  <completion_date type="Anticipated">October 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>maternal microbiome</measure>
    <time_frame>2020-2023</time_frame>
    <description>difference between non-pregnant and pregnant women</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fetal/neonatal microbiome</measure>
    <time_frame>2020-2023</time_frame>
    <description>difference between vaginal and C-section born infants</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Human milk oligosaccharides</measure>
    <time_frame>2020-2023</time_frame>
    <description>associations of HMOs with maternal/infant microbiome</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Microbial Colonization</condition>
  <arm_group>
    <arm_group_label>non-pregnant women</arm_group_label>
    <description>Samples will be collected from 30 healthy, non-pregnant women in the reproductive age: blood, urine, stool, saliva, oral swabs, vaginal swabs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pregnant women delivering vaginally</arm_group_label>
    <description>From 30 healthy, pregnant women giving vaginal birth, samples will be collected shortly before, during and after birth from maternal and newborn sites:&#xD;
maternal blood, urine, stool, saliva, oral swabs, vaginal swabs; cord blood, colostrum, meconium, infant oral swabs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pregnant women undergoing C-section</arm_group_label>
    <description>From 30 healthy, pregnant women giving vaginal birth, samples will be collected shortly before, during and after birth from maternal and newborn sites:&#xD;
maternal blood, urine, stool, saliva, oral swabs, vaginal swabs; amniotic fluid, cord blood, colostrum, meconium, infant oral swabs</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      from non-pregnant and pregnant women: serum, urine, oral swabs, vaginal swabs, stool&#xD;
&#xD;
      from pregnant women undergoing C-section: amniotic fluid&#xD;
&#xD;
      from newborn babies: cord blood, oral swabs, meconium, stool sample of day 1-3&#xD;
&#xD;
      colostrum and breast milk samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy non-pregnant women and women with an ongoing healthy pregnancy. 3 groups will be&#xD;
        formed: non-pregnant women (n=30), women delivering vaginally (n=30) and women undergoing&#xD;
        C-section (n=30).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthy women&#xD;
&#xD;
          -  pregnant women: delivery at term (gestational age 37-42); contractions or rupture of&#xD;
             membrane no longer than 12h before admission to hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  bacterial/ fungal infections&#xD;
&#xD;
          -  use of antibiotics/ probiotics in past 3 months&#xD;
&#xD;
          -  fetal anomalies&#xD;
&#xD;
          -  multiple pregnancies&#xD;
&#xD;
          -  diabetes type 1, 2, gestational diabetes&#xD;
&#xD;
          -  hypertension, preeclampsia/HELLP&#xD;
&#xD;
          -  HIV ( human immunodeficiency virus), HCV (Hepatitis C)&#xD;
&#xD;
          -  drug abuse, smoking&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evelyn Jantscher-Krenn, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christine Moissl-Eichinger, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Graz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evelyn Jantscher-Krenn, PhD</last_name>
    <phone>+43 385 316</phone>
    <phone_ext>80076</phone_ext>
    <email>evelyn.jantscher-krenn@medunigraz.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christine Moissl-Eichinger, PhD</last_name>
    <phone>+43 385 316</phone>
    <phone_ext>72808</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <zip>8043</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vassiliki Kolovetsiou-Kreiner, MD</last_name>
      <phone>+43 385 316</phone>
      <phone_ext>80643</phone_ext>
      <email>vassiliki.kolovetsiou@medunigraz.at</email>
    </contact>
    <contact_backup>
      <last_name>Eva-Christine Weiss, MD</last_name>
      <phone>+43 385 316</phone>
      <phone_ext>80840</phone_ext>
      <email>ev.weiss@medunigraz.at</email>
    </contact_backup>
    <investigator>
      <last_name>Christine Moissl-Eichinger, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Evelyn Jantscher-Krenn, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 24, 2019</study_first_submitted>
  <study_first_submitted_qc>October 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2019</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

